Article
The role of RAS mutations in MLL-rearranged leukaemia: A path to intervention?
Biochimica et biophysica acta. Reviews on cancer - 1 Dec 2017
Mansur Marcela B, Ford Anthony M, Emerenciano Mariana
Abstract excerpt
Childhood acute lymphoblastic leukaemia (ALL) with MLL rearrangement (MLL-r) is an aggressive disease still associated with a high mortality rate. Recent investigations have identified co-operating mutations in the RAS pathway and although the functional consequences of these mutations are not yet fully understood, aberrant regulation of RAS pathway signalling at both transcriptional and protein levels is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
